| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 04/20/2005 | CN1608055A Compounds for the treatment of metabolic disorders |
| 04/20/2005 | CN1607960A Glycoprotein compositions |
| 04/20/2005 | CN1607958A Liquid composition of modified factor vii polypeptides |
| 04/20/2005 | CN1607952A Pharmaceutical compositions comprising a multifunctional phosphodiesterase inhibitor and an adenosine uptake inhibitor |
| 04/20/2005 | CN1607949A Peptide arginals and methods for treating disseminated intravascular coagulation |
| 04/20/2005 | CN1607211A Poly asparaginyl aminoacetic acid, alanine and lysine and its preparation method and medicament purpose |
| 04/20/2005 | CN1606986A Wolf'sclaw (Selaginella moellendorffii Hieron)dry powder extracted using alcohol, and its preparation method |
| 04/20/2005 | CN1197872C Polypeptide with alpha-galactosidase activity and its coding nucleic acid |
| 04/20/2005 | CN1197623C Sparagin injection using xylitol as isosmotic adjusting agent |
| 04/20/2005 | CN1197572C Hypoalbuminemia improvement agent |
| 04/19/2005 | US6881754 Adamantane derivatives |
| 04/19/2005 | US6881739 Use of cortisol antagonists in the treatment of heart failure |
| 04/19/2005 | US6881735 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 04/19/2005 | US6881730 Steroid compounds with a c17-alkyl side chain and an aromatic a-ring for use in therapy |
| 04/19/2005 | US6881722 Polypeptide Saratin for the manufacture of a medicament having the capability to significantly decrease platelet adhesion and platelet accumulation after vascular injuries or endarterectomy. The invention furthermore relates to novel |
| 04/19/2005 | US6881721 Medicinal compositions for treating and preventing diseases based on abnormal blood coagulation |
| 04/19/2005 | CA2334155C Cyclic boroproline compounds |
| 04/14/2005 | WO2005033254A1 Body fat burn spurring perfume composition |
| 04/14/2005 | WO2005033140A1 Highly pure blood coagulation factor ix preparation and method of purifying the same |
| 04/14/2005 | WO2005033123A1 Stable vitamin b6 derivative |
| 04/14/2005 | WO2005032566A1 Method of replenishing cells damaged by treatment for cancer |
| 04/14/2005 | WO2005032488A2 2,4-dioxo-3-quinazolinylaryl sulfonylureas |
| 04/14/2005 | WO2005011645A3 Selected betaines and their uses |
| 04/14/2005 | WO2005000281A3 Pyrazolidinedione derivatives and their use as platelet aggregation inhibitors |
| 04/14/2005 | US20050080117 Substituted benzoxazoles as estrogenic agents |
| 04/14/2005 | US20050080081 Substituted oxazolidinones and their use in the field of blood coagulation |
| 04/14/2005 | US20050080051 for the treatment of hyperlipidemia and blood coagulation disorders; phosphatidylinositol, phosphatidylserine, phosphatidylglycerol, or phosphatidic acid; dyslipidemia and atherosclerosis |
| 04/14/2005 | US20050080046 In liquid solvent; parenterally administering; aldosterone receptors blockers; congestive heart failure, hypotensive agents, liver disorders |
| 04/14/2005 | US20050080042 synthetic monosaccharides, disaccharides, trisaccharides, tetrasaccharides and pentasaccharides for use in the preparation of synthetic heparinoids; Vascular thrombosis, cardiovascular disease |
| 04/14/2005 | US20050080029 Administering to the cell the compound to be delivered, an organic halide, and/or a carrier; ultrasound may also be applied |
| 04/14/2005 | US20050080026 Nucleic acid molecule of MAP kinase interacting kinase gene family or polypeptide encoded thereby or fragment or variant of nucleic acid molecule, polypeptide or antibody, aptamer or receptor recognizing a nucleic acid molecule of gene family or polypeptide encoded thereby; treating metabolic diseases |
| 04/14/2005 | US20050080014 Thrombopoietic compounds |
| 04/14/2005 | US20050080009 Storage-stable, liquid fibrinogen formulation |
| 04/14/2005 | US20050080008 Administering bactericidal permeability increasing protein products; anticoagulants; without severe adverse side effects |
| 04/14/2005 | US20050079584 Modified factor VIII |
| 04/14/2005 | US20050079541 Immunoadhesin comprising a glycorprotein v1 domain |
| 04/14/2005 | US20050079537 Expression vector comprising nucleotide sequences coding membrane protein for in identifying modulator for prevention and treatment of cell proliferative, nervous system and inflammatory disorders |
| 04/14/2005 | US20050079179 Compositions and methods for producing vascular occlusion |
| 04/14/2005 | US20050079176 Treating stress response with chemokine receptor ccr5 modulators |
| 04/14/2005 | US20050079162 Method for improving oxygen transport by stored red blood cells |
| 04/14/2005 | US20050079148 Biocompatible polymer designed to release nitric oxide; extensively cross-linked polyamine-derivatized divinylbenzene; sustained release, potentiation |
| 04/14/2005 | DE10342108A1 Basisch-substituierte Benzylaminanaloga als Inhibitoren des Gerinnungsfaktors Xa, ihre Herstellung und Verwendung Basic-substituted Benzylaminanaloga as inhibitors of coagulation factor Xa, their preparation and use |
| 04/14/2005 | CA2544574A1 Stable vitamin b6 derivative |
| 04/14/2005 | CA2537314A1 Method of replenishing cells damaged by treatment for cancer |
| 04/13/2005 | EP1522318A2 Heat stable coated colloidal iron oxides |
| 04/13/2005 | EP1522312A1 Biologically stable liquid composition of FVIII, of vWF or of FVIII/vWF complex of human origin. |
| 04/13/2005 | EP1521839A1 Methods of making viral particles having a modified cell binding activity and uses thereof |
| 04/13/2005 | EP1521824A2 Nucleic acid-associated proteins |
| 04/13/2005 | EP1521766A2 SPLICEOSOME MEDIATED RNA i TRANS /i -SPLICING AND CORRECTION OF FACTOR VIII GENETIC DEFECTS USING SPLICEOSOME MEDIATED RNA TRANS SPLING |
| 04/13/2005 | EP1521733A1 Modulators of the glucocorticoid receptor |
| 04/13/2005 | EP1366050B1 Condensed pyrazindione derivatives as pde inhibitors |
| 04/13/2005 | EP1303296B1 Composition containing an iron complexing protein and a precursor of nitrogen monoxide metabolism and/or a chemical donor of nitrogen monoxide and uses thereof |
| 04/13/2005 | EP1289955B1 Piperidines for use as orexin receptor antagonists |
| 04/13/2005 | EP1268498B1 Cardioprotective phosphonates |
| 04/13/2005 | EP1073453B1 Use of angiotensin analogs for the manufacture of a medicament for increasing white blood cell survival and mobilizing haematopoietic progenitor cells following chemotherapy |
| 04/13/2005 | EP0728210B1 Thrombin mutants |
| 04/13/2005 | CN1606568A Process for the purification and/or isolation of biologically active granulocyte colony stimulating factor |
| 04/13/2005 | CN1606557A Deuterated pyrazolopyrimidinones and drugs containing said compounds |
| 04/13/2005 | CN1606555A Imidazoquinoline derivatives |
| 04/13/2005 | CN1606554A Beta-lactamyl vasopressin v1aantagonists |
| 04/13/2005 | CN1606457A Methods for sterilizing preparations containing albumin |
| 04/13/2005 | CN1606452A Liquid composition of modified factor vii polypeptides |
| 04/13/2005 | CN1606447A Storage-stable fibrinogen solutions |
| 04/13/2005 | CN1606444A Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 04/13/2005 | CN1606432A Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules |
| 04/13/2005 | CN1605346A Vacuum-electrolysis and flocculation reclaiming technology for preparing |
| 04/13/2005 | CN1605339A Usage of 1H-indole-2, 3-diketone and its derivant in the process for preparing anemia treating medicine and medicine for treating anemia |
| 04/13/2005 | CN1196784C Promoter of human endoglin gene and its use |
| 04/13/2005 | CN1196713C Process for preparing cross-linked haematoglobin as substitute of red blood cell |
| 04/13/2005 | CN1196709C Troxerutin with high trihydroxy-ethyl-rutin content and method for preparing same |
| 04/13/2005 | CN1196696C New thiochromane derivatives and use as thrombin inhibitors |
| 04/13/2005 | CN1196481C Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent |
| 04/12/2005 | US6878828 Coupling cysteine with benzonitrile, then esterifying, alkylating, hydrolyzing and reacting with acids to form 2-methylcysteine |
| 04/12/2005 | US6878826 Perfluoronated cycle-containing tertiary amines used as a basis for gas-conveying emulsions and device for the production thereof |
| 04/12/2005 | US6878813 Elastase-resistant antithrombin III (ATIII) for treating blood clotting disorders |
| 04/12/2005 | US6878729 Antihypoxic agents |
| 04/12/2005 | US6878726 For therapy and prophylaxis inflammation, other inflammation associated disorders, such as arthritis, neurodegeneration and colon cancer, in mammals, dogs, cats or livestock animals |
| 04/12/2005 | US6878725 Serine protease inhibitors |
| 04/12/2005 | US6878711 Indole derivatives as PDE5-inhibitors |
| 04/12/2005 | US6878710 Bicyclic inhibitors of factor Xa |
| 04/12/2005 | US6878709 Treating acute and chronic inflammatory disorders and cancer. |
| 04/12/2005 | US6878708 Imidazotriazinones and the use thereof |
| 04/12/2005 | CA2278106C Tissue factor methods and compositions for coagulation and tumor treatment |
| 04/12/2005 | CA2229316C Calcitriol derivatives and their uses |
| 04/12/2005 | CA2142445C Injection solutions of azosemide which are ready for injection |
| 04/12/2005 | CA2131229C Bisconjugates comprising two saccharides and a spacer |
| 04/12/2005 | CA2122571C Adhesion receptor antagonists |
| 04/12/2005 | CA2081836C Aromatic amidine derivatives and salts thereof |
| 04/12/2005 | CA1341479C Hybrid single-chain plasminogen activators |
| 04/07/2005 | WO2005030975A1 METHOD OF PREPARING α-GLYCOSYLISOQUERCITRIN, INTERMEDIATE THEREFOR, AND BY-PRODUCT |
| 04/07/2005 | WO2005030785A2 Novel thioxylose compounds, preparation method thereof, pharmaceutical compositions containing same and use thereof in therapeutics |
| 04/07/2005 | WO2005030759A1 Carbamoyl-type benzofuran derivatives |
| 04/07/2005 | WO2005030756A1 Substituted pyrrole-indoles as inhibitors of pai-1 |
| 04/07/2005 | WO2005030740A1 Thiazoline derivative and use of the same |
| 04/07/2005 | WO2005030716A1 Heterocyclic- or aryloxy, -thio or -amino substituted indoles-2-carboxylic acids or esters as pai-1 |
| 04/07/2005 | WO2005030715A1 Substituted sulfonamide-indole-2-carboxylic acid derivatives as pai-1 inhibitors |
| 04/07/2005 | WO2005030706A1 Amide type carboxamide derivative |
| 04/07/2005 | WO2005030235A1 Method of processing ginseng for medicinal use and composition |
| 04/07/2005 | WO2005030204A1 Substituted oxadiazolidinediones as pai-1 inhibitors |
| 04/07/2005 | WO2005030203A1 Substituted oxadiazolidinediones als pai-1 inhibitors |